H1N1 (Swine Influenza) - Epidemiology Forecast to 2032

January 2022 | 60 pages | ID: H01BCEB9C18EN
DelveInsight

Abstracts

This report can be delivered to the clients within 5-7 Business Days

DelveInsight's 'H1N1 (Swine Influenza) - Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease, historical and forecasted H1N1 (Swine Influenza) epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.

Geographies Covered

• The United States
• EU5 (Germany, France, Italy, Spain, and the United Kingdom)
• Japan

Study Period: 2019-2032

H1N1 (Swine Influenza) Understanding

The DelveInsight H1N1 (Swine Influenza) epidemiology report gives a thorough understanding of the H1N1 (Swine Influenza) by including details such as disease definition, symptoms, causes, pathophysiology, and diagnosis. It also provides treatment algorithms and treatment guidelines for H1N1 (Swine Influenza) in the US, Europe, and Japan. The report covers the detailed information of the H1N1 (Swine Influenza) epidemiology scenario in seven major countries (US, EU5, and Japan).

H1N1 (Swine Influenza) Epidemiology Perspective by DelveInsight

The H1N1 (Swine Influenza) epidemiology division provides insights about historical and current patient pool and forecasted trend for every seven major countries. The H1N1 (Swine Influenza) epidemiology data are studied through all possible division to give a better understanding of the Disease scenario in 7MM. The H1N1 (Swine Influenza) epidemiology segment covers the epidemiology data in the US, EU5 countries (Germany, Spain, Italy, France, and the UK), and Japan from 2019 to 2032. It also helps recognize the causes of current and forecasted trends by exploring numerous studies, survey reports and views of key opinion leaders.

H1N1 (Swine Influenza) Detailed Epidemiology Segmentation

The H1N1 (Swine Influenza) epidemiology covered in the report provides historical as well as forecasted H1N1 (Swine Influenza) epidemiology scenario in the 7MM covering the United States, EU5 countries (Germany, Spain, Italy, France, and the United Kingdom), and Japan from 2019 to 2032.

The DelveInsight H1N1 (Swine Influenza) report also provides the epidemiology trends observed in the 7MM during the study period, along with the assumptions undertaken. The calculated data are presented with relevant tables and graphs to give a clear view of the epidemiology at first sight.

Scope of the Report

• The H1N1 (Swine Influenza) report covers a detailed overview explaining its causes, symptoms, classification, pathophysiology, diagnosis and treatment patterns
• The H1N1 (Swine Influenza) Epidemiology Report and Model provide an overview of the global trends of H1N1 (Swine Influenza) in the seven major markets (7MM: US, France, Germany, Italy, Spain, UK, and Japan)
• The report provides insight into the historical and forecasted patient pool of H1N1 (Swine Influenza) in seven major markets covering the United States, EU5 (Germany, Spain, France, Italy, UK), and Japan
• The report helps recognize the growth opportunities in the 7MM for the patient population
• The report assesses the disease risk and burden and highlights the unmet needs of H1N1 (Swine Influenza)
• The report provides the segmentation of the H1N1 (Swine Influenza) epidemiology

Report Highlights

• 11-year Forecast of H1N1 (Swine Influenza) epidemiology
• 7MM Coverage
• Prevalent and Diagnosed Cases of H1N1 (Swine Influenza)
• Cases of H1N1 (Swine Influenza) by Mutation Types
• H1N1 (Swine Influenza) Cases associated with Clinical Manifestations

KOL views

We interview, KOLs and SME's opinion through primary research to fill the data gaps and validate our secondary research. The opinion helps understand the total patient population and current treatment pattern. This will support the clients in potential upcoming novel treatment by identifying the overall scenario of the indications.

Key Questions Answered

• What will be the growth opportunities in the 7MM with respect to the patient population pertaining to H1N1 (Swine Influenza)?
• What are the key findings pertaining to the H1N1 (Swine Influenza) epidemiology across 7MM and which country will have the highest number of patients during the forecast period (2019-2032)?
• What would be the total number of patients of H1N1 (Swine Influenza) across the 7MM during the forecast period (2019-2032)?
• Among the EU5 countries, which country will have the highest number of patients during the forecast period (2019-2032)?
• At what CAGR the patient population is expected to grow in 7MM during the forecast period (2019-2032)?
• What is the disease risk, burden and unmet needs of H1N1 (Swine Influenza)?
• What are the currently available treatments of H1N1 (Swine Influenza)?

Reasons to buy

The H1N1 (Swine Influenza) Epidemiology report will allow the user to -

• Develop business strategies by understanding the trends shaping and driving the global H1N1 (Swine Influenza) market
• Quantify patient populations in the global H1N1 (Swine Influenza) market to improve product design, pricing, and launch plans
• Organize sales and marketing efforts by identifying the age groups and sex that present the best opportunities for H1N1 (Swine Influenza) therapeutics in each of the markets covered
• Understand the magnitude of H1N1 (Swine Influenza) population by its epidemiology
• The H1N1 (Swine Influenza) Epidemiology Model developed by DelveInsight is easy to navigate, interactive with dashboards, and epidemiology based with transparent and consistent methodologies. Moreover, the model supports data presented in the report and showcases disease trends over 11-year forecast period using reputable sources

Key Assessments

• Patient Segmentation
• Disease Risk & Burden
• Risk of disease by the segmentation
• Factors driving growth in a specific patient population

Contents

1. KEY INSIGHTS

2. EXECUTIVE SUMMARY OF H1N1 (SWINE INFLUENZA)

3. H1N1 (SWINE INFLUENZA): DISEASE BACKGROUND AND OVERVIEW

3.1. Introduction
3.2. Sign and Symptoms
3.3. Pathophysiology
3.4. Risk Factors
3.5. Diagnosis

4. PATIENT JOURNEY

5. EPIDEMIOLOGY AND PATIENT POPULATION

5.1. Epidemiology Key Findings
5.2. Assumptions and Rationale: 7MM
5.3. Epidemiology Scenario: 7MM
  5.3.1. H1N1 (Swine Influenza) Epidemiology Scenario in the 7MM (2019- 2032)
5.4. United States Epidemiology
  5.4.1. H1N1 (Swine Influenza) Epidemiology Scenario in the United States (2019- 2032)
5.5. EU-5 Country-wise Epidemiology
  5.5.1. Germany Epidemiology
    5.5.1.1. H1N1 (Swine Influenza) Epidemiology Scenario in Germany (2019- 2032)
  5.5.2. France Epidemiology
    5.5.2.1. H1N1 (Swine Influenza) Epidemiology Scenario in France (2019- 2032)
  5.5.3. Italy Epidemiology
    5.5.3.1. H1N1 (Swine Influenza) Epidemiology Scenario in Italy (2019- 2032)
  5.5.4. Spain Epidemiology
    5.5.4.1. H1N1 (Swine Influenza) Epidemiology Scenario in Spain (2019- 2032)
  5.5.5. United Kingdom Epidemiology
    5.5.5.1. H1N1 (Swine Influenza) Epidemiology Scenario in the United Kingdom (2019-2032)
5.6. Japan Epidemiology
  5.6.1. H1N1 (Swine Influenza) Epidemiology Scenario in Japan (2019- 2032)

6. TREATMENT ALGORITHM, CURRENT TREATMENT, AND MEDICAL PRACTICES

6.1. H1N1 (Swine Influenza) Treatment and Management
6.2. H1N1 (Swine Influenza) Treatment Algorithm

7. KOL VIEWS

8. UNMET NEEDS

9. APPENDIX

9.1. Bibliography
9.2. Report Methodology

10. DELVEINSIGHT CAPABILITIES

11. DISCLAIMER

12. ABOUT DELVEINSIGHT

*The table of contents is not exhaustive; will be provided in the final report

List Of Tables

LIST OF TABLES

List of Table:
Table 1: H1N1 (Swine Influenza) Epidemiology in 7MM (2019-2032)
Table 2: H1N1 (Swine Influenza) Diagnosed and Treatable Cases in 7MM (2019-2032)
Table 3: H1N1 (Swine Influenza) Epidemiology in the United States (2019-2032)
Table 4: H1N1 (Swine Influenza) Diagnosed and Treatable Cases in the United States (2019-2032)
Table 5: H1N1 (Swine Influenza) Epidemiology in Germany (2019-2032)
Table 6: H1N1 (Swine Influenza) Diagnosed and Treatable Cases in Germany (2019-2032)
Table 7: H1N1 (Swine Influenza) Epidemiology in France (2019-2032)
Table 8: H1N1 (Swine Influenza) Diagnosed and Treatable Cases in France (2019-2032)
Table 9: H1N1 (Swine Influenza) Epidemiology in Italy (2019-2032)
Table 10: H1N1 (Swine Influenza) Diagnosed and Treatable Cases in Italy (2019-2032)
Table 11: H1N1 (Swine Influenza) Epidemiology in Spain (2019-2032)
Table 12: H1N1 (Swine Influenza) Diagnosed and Treatable Cases in Spain (2019-2032)
Table 13: H1N1 (Swine Influenza) Epidemiology in the United Kingdom (2019-2032)
Table 14: H1N1 (Swine Influenza) Diagnosed and Treatable Cases in the United Kingdom (2019-2032)
Table 15: H1N1 (Swine Influenza) Epidemiology in Japan (2019-2032)
Table 16: H1N1 (Swine Influenza) Diagnosed and Treatable Cases in Japan (2019-2032)

List Of Figures

LIST OF FIGURES

List of Figures
Figure 1 H1N1 (Swine Influenza) Epidemiology in 7MM (2019-2032)
Figure 2 H1N1 (Swine Influenza) Diagnosed and Treatable Cases in 7MM (2019-2032)
Figure 3 H1N1 (Swine Influenza) Epidemiology in the United States (2019-2032)
Figure 4 H1N1 (Swine Influenza) Diagnosed and Treatable Cases in the United States (2019-2032)
Figure 5 H1N1 (Swine Influenza) Epidemiology in Germany (2019-2032)
Figure 6 H1N1 (Swine Influenza) Diagnosed and Treatable Cases in Germany (2019-2032)
Figure 7 H1N1 (Swine Influenza) Epidemiology in France (2019-2032)
Figure 8 H1N1 (Swine Influenza) Diagnosed and Treatable Cases in France (2019-2032)
Figure 9 H1N1 (Swine Influenza) Epidemiology in Italy (2019-2032)
Figure 10 H1N1 (Swine Influenza) Diagnosed and Treatable Cases in Italy (2019-2032)
Figure 11 H1N1 (Swine Influenza) Epidemiology in Spain (2019-2032)
Figure 12 H1N1 (Swine Influenza) Diagnosed and Treatable Cases in Spain (2019-2032)
Figure 13 H1N1 (Swine Influenza) Epidemiology in the United Kingdom (2019-2032)
Figure 14 H1N1 (Swine Influenza) Diagnosed and Treatable Cases in the United Kingdom (2019-2032)
Figure 15 H1N1 (Swine Influenza) Epidemiology in Japan (2019-2032)
Figure 16 H1N1 (Swine Influenza) Diagnosed and Treatable Cases in Japan (2019-2032)
*The table of contents is not exhaustive; will be provided in the final report